Acquiring Company
Abbott
Acquired Company
Surmodics
Eden PrairieBiotechnologyHealth CareMedicalManufacturingBiotechnologyHealth CareMedicalMedical DeviceDescription
Surmodics has agreed to be acquired by Abbott in a deal worth approximately $1.4 billion. This acquisition comes as Surmodics reports growth in its medical device segment. The acquisition is expected to enhance Abbott's portfolio in the medtech space.
Quick answer
Abbott is acquiring Surmodics for $1.4 billion, announced May 19, 2026.
- How much did Abbott pay for Surmodics?
- The reported deal value is $1.4 billion.
- What does Abbott do?
- Abbott is a global healthcare leader that helps people live more fully at all stages of life.
- Where are Abbott and Surmodics based?
- Surmodics is based in Eden Prairie, Minnesota, United States.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Alkem Medtech to acquire majority stake in Occlutech (June 29, 2026)
- Everis Medical acquires Hood Laboratories for growth (May 20, 2026)
- Medtronic to acquire SPR Therapeutics for chronic pain care (May 20, 2026)
- AP Technologies acquires Blueacre Technology for growth (May 19, 2026)
- Advanced Bifurcation Systems Acquires Svelte Medical (April 27, 2026)
- Oury Medical acquires Céfiméca for growth strategy (April 6, 2026)
Who to call at Abbott, and when
When Abbott changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Abbott raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Abbott, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Abbott. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Abbott makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Surmodics?
Surmodics was acquired by Abbott. The deal was reported on May 19, 2026. Abbott is a global healthcare leader that helps people live more fully at all stages of life. Abbott is privately held and operates in Biotechnology.
When did Abbott acquire Surmodics?
Abbott's acquisition of Surmodics was reported on May 19, 2026. Surmodics has agreed to be acquired by Abbott in a deal worth approximately $1.4 billion. This acquisition comes as Surmodics reports growth in its medical device segment. The acquisition is expected to enhance Abbott's portfolio in the medtech space. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Surmodics do?
Surmodics is a leading provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. It is privately held, operating in Manufacturing, and is based in Eden Prairie.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.